000			02170na a2200217 4500
999			_c254 _d254
003			PC254
005			20191029112248.0
008			130622s2013 xxx||||| |||| 00| 0 eng d
040			_cH12O
041			_aeng
100			_aRodríguez Antolín, Alfredo _91692 _eUrología
245	0	0	_aSeverity Profiles in Patients Diagnosed of Benign Prostatic Hyperplasia in Spain _h[artículo]
260			_bActas urologicas españolas, _c2013
300			_a37(9):544-8.
500			_aFormato Vancouver: Miñana B, Rodríguez-Antolín A, Prieto M, Pedrosa E. Severity profiles in patients diagnosed of benign prostatic hyperplasia in Spain. Actas Urol Esp. 2013 Oct;37(9):544-8.
501			_aPMID:23856059
504			_aContiene 19 referencias
520			_aObjectives: To analyse the severity profiles and progression criteria in patients diagnosed of benign prostatic hyperplasia (BPH) in urology clinics in Spain. Material and methods: A multicentre observational epidemiological study conducted in Spain between May-November 2008. A representative sample of 392 urologist gathered sociodemographic, clinical and patient-centered data from three consecutive patients with new diagnostic of BPH in urology clinics. Results: A total of 1.115 patients were evaluated. Mean age was 65.7 years old. Mean time from the onset of symptoms to diagnostic was18,8 months. Mean IPSS score was 17.2. 63 patients (5,7%) had mild symptoms; 670 (60,1%) had moderate symptoms with a mean IPSS score of 14.6 and 382 (34.3%) had severe symptoms with a mean IPSS score of 23.7. Mean PSA was 2.6 ng/ml and ultrasound measured prostatic volume was 49.2 cc. A total of 713 (63,9%) patients met progression criteria (PSA >1.5 ng/ml and volume > 30 cc). Symptoms severity was directly correlated with age, prostatic volume, PSA, presence of progression criteria and time from the onset of symptoms and inversely correlated with urine flow rate (P < .001). Progression criteria was directly correlated with age, symptoms severity and inversely with urine flow rate (P < .01). Conclusions: More than 90% of patients diagnosed of BPH in urology clinics in Spain had moderate to severe symptoms. Two thirds met progression criteria that correlate with age and severity of symptoms.
710			_9220 _aServicio de Urología
856			_uhttp://pc-h12o-es.m-hdoct.a17.csinet.es/pdf/pc/2/pc254.pdf _ySolicitar documento
942			_n0 _2ddc _cART